Cargando…
Uptake and effect of universal test-and-treat on twelve months retention and initial virologic suppression in routine HIV program in Kenya
Early combination antiretroviral therapy (cART), as recommended in WHO’s universal test-and-treat (UTT) policy, is associated with improved linkage to care, retention, and virologic suppression in controlled studies. We aimed to describe UTT uptake and effect on twelve-month non-retention and initia...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681077/ https://www.ncbi.nlm.nih.gov/pubmed/36413522 http://dx.doi.org/10.1371/journal.pone.0277675 |
_version_ | 1784834538408509440 |
---|---|
author | Kimanga, Davies O. Oramisi, Violet A. Hassan, Amin S. Mugambi, Mary K. Miruka, Frederick O. Muthoka, Kennedy J. Odhiambo, Jacob O. Yegon, Peter K. Omoro, Gonza O. Mbaire, Catherine Masamaro, Kenneth M. Njogo, Susan M. Barker, Joseph L Ngugi, Catherine N. |
author_facet | Kimanga, Davies O. Oramisi, Violet A. Hassan, Amin S. Mugambi, Mary K. Miruka, Frederick O. Muthoka, Kennedy J. Odhiambo, Jacob O. Yegon, Peter K. Omoro, Gonza O. Mbaire, Catherine Masamaro, Kenneth M. Njogo, Susan M. Barker, Joseph L Ngugi, Catherine N. |
author_sort | Kimanga, Davies O. |
collection | PubMed |
description | Early combination antiretroviral therapy (cART), as recommended in WHO’s universal test-and-treat (UTT) policy, is associated with improved linkage to care, retention, and virologic suppression in controlled studies. We aimed to describe UTT uptake and effect on twelve-month non-retention and initial virologic non-suppression (VnS) among HIV infected adults starting cART in routine HIV program in Kenya. Individual-level HIV service delivery data from 38 health facilities, each representing 38 of the 47 counties in Kenya were analysed. Adults (>15 years) initiating cART between the second-half of 2015 (2015HY2) and the first-half of 2018 (2018HY1) were followed up for twelve months. UTT was defined based on time from an HIV diagnosis to cART initiation and was categorized as same-day, 1–14 days, 15–90 days, and 91+ days. Non-retention was defined as individuals lost-to-follow-up or reported dead by the end of the follow up period. Initial VnS was defined based on the first available viral load test with >400 copies/ml. Hierarchical mixed-effects survival and generalised linear regression models were used to assess the effect of UTT on non-retention and VnS, respectively. Of 8592 individuals analysed, majority (n = 5864 [68.2%]) were female. Same-day HIV diagnosis and cART initiation increased from 15.3% (2015HY2) to 52.2% (2018HY1). The overall non-retention rate was 2.8 (95% CI: 2.6–2.9) per 100 person-months. When compared to individuals initiated cART 91+ days after a HIV diagnosis, those initiated cART on the same day of a HIV diagnosis had the highest rate of non-retention (same-day vs. 91+ days; aHR, 1.7 [95% CI: 1.5–2.0], p<0.001). Of those included in the analysis, 5986 (69.6%) had a first viral load test done at a median of 6.3 (IQR, 5.6–7.6) months after cART initiation. Of these, 835 (13.9%) had VnS. There was no association between UTT and VnS (same-day vs. 91+ days; aRR, 1.0 [95% CI: 0.9–1.2], p = 0.664). Our findings demonstrate substantial uptake of the UTT policy but poor twelve-month retention and lack of an association with initial VnS from routine HIV settings in Kenya. These findings warrant consideration for multi-pronged program interventions alongside UTT policy for maximum intended benefits in Kenya. |
format | Online Article Text |
id | pubmed-9681077 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-96810772022-11-23 Uptake and effect of universal test-and-treat on twelve months retention and initial virologic suppression in routine HIV program in Kenya Kimanga, Davies O. Oramisi, Violet A. Hassan, Amin S. Mugambi, Mary K. Miruka, Frederick O. Muthoka, Kennedy J. Odhiambo, Jacob O. Yegon, Peter K. Omoro, Gonza O. Mbaire, Catherine Masamaro, Kenneth M. Njogo, Susan M. Barker, Joseph L Ngugi, Catherine N. PLoS One Research Article Early combination antiretroviral therapy (cART), as recommended in WHO’s universal test-and-treat (UTT) policy, is associated with improved linkage to care, retention, and virologic suppression in controlled studies. We aimed to describe UTT uptake and effect on twelve-month non-retention and initial virologic non-suppression (VnS) among HIV infected adults starting cART in routine HIV program in Kenya. Individual-level HIV service delivery data from 38 health facilities, each representing 38 of the 47 counties in Kenya were analysed. Adults (>15 years) initiating cART between the second-half of 2015 (2015HY2) and the first-half of 2018 (2018HY1) were followed up for twelve months. UTT was defined based on time from an HIV diagnosis to cART initiation and was categorized as same-day, 1–14 days, 15–90 days, and 91+ days. Non-retention was defined as individuals lost-to-follow-up or reported dead by the end of the follow up period. Initial VnS was defined based on the first available viral load test with >400 copies/ml. Hierarchical mixed-effects survival and generalised linear regression models were used to assess the effect of UTT on non-retention and VnS, respectively. Of 8592 individuals analysed, majority (n = 5864 [68.2%]) were female. Same-day HIV diagnosis and cART initiation increased from 15.3% (2015HY2) to 52.2% (2018HY1). The overall non-retention rate was 2.8 (95% CI: 2.6–2.9) per 100 person-months. When compared to individuals initiated cART 91+ days after a HIV diagnosis, those initiated cART on the same day of a HIV diagnosis had the highest rate of non-retention (same-day vs. 91+ days; aHR, 1.7 [95% CI: 1.5–2.0], p<0.001). Of those included in the analysis, 5986 (69.6%) had a first viral load test done at a median of 6.3 (IQR, 5.6–7.6) months after cART initiation. Of these, 835 (13.9%) had VnS. There was no association between UTT and VnS (same-day vs. 91+ days; aRR, 1.0 [95% CI: 0.9–1.2], p = 0.664). Our findings demonstrate substantial uptake of the UTT policy but poor twelve-month retention and lack of an association with initial VnS from routine HIV settings in Kenya. These findings warrant consideration for multi-pronged program interventions alongside UTT policy for maximum intended benefits in Kenya. Public Library of Science 2022-11-22 /pmc/articles/PMC9681077/ /pubmed/36413522 http://dx.doi.org/10.1371/journal.pone.0277675 Text en https://creativecommons.org/publicdomain/zero/1.0/This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication. |
spellingShingle | Research Article Kimanga, Davies O. Oramisi, Violet A. Hassan, Amin S. Mugambi, Mary K. Miruka, Frederick O. Muthoka, Kennedy J. Odhiambo, Jacob O. Yegon, Peter K. Omoro, Gonza O. Mbaire, Catherine Masamaro, Kenneth M. Njogo, Susan M. Barker, Joseph L Ngugi, Catherine N. Uptake and effect of universal test-and-treat on twelve months retention and initial virologic suppression in routine HIV program in Kenya |
title | Uptake and effect of universal test-and-treat on twelve months retention and initial virologic suppression in routine HIV program in Kenya |
title_full | Uptake and effect of universal test-and-treat on twelve months retention and initial virologic suppression in routine HIV program in Kenya |
title_fullStr | Uptake and effect of universal test-and-treat on twelve months retention and initial virologic suppression in routine HIV program in Kenya |
title_full_unstemmed | Uptake and effect of universal test-and-treat on twelve months retention and initial virologic suppression in routine HIV program in Kenya |
title_short | Uptake and effect of universal test-and-treat on twelve months retention and initial virologic suppression in routine HIV program in Kenya |
title_sort | uptake and effect of universal test-and-treat on twelve months retention and initial virologic suppression in routine hiv program in kenya |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681077/ https://www.ncbi.nlm.nih.gov/pubmed/36413522 http://dx.doi.org/10.1371/journal.pone.0277675 |
work_keys_str_mv | AT kimangadavieso uptakeandeffectofuniversaltestandtreatontwelvemonthsretentionandinitialvirologicsuppressioninroutinehivprograminkenya AT oramisivioleta uptakeandeffectofuniversaltestandtreatontwelvemonthsretentionandinitialvirologicsuppressioninroutinehivprograminkenya AT hassanamins uptakeandeffectofuniversaltestandtreatontwelvemonthsretentionandinitialvirologicsuppressioninroutinehivprograminkenya AT mugambimaryk uptakeandeffectofuniversaltestandtreatontwelvemonthsretentionandinitialvirologicsuppressioninroutinehivprograminkenya AT mirukafredericko uptakeandeffectofuniversaltestandtreatontwelvemonthsretentionandinitialvirologicsuppressioninroutinehivprograminkenya AT muthokakennedyj uptakeandeffectofuniversaltestandtreatontwelvemonthsretentionandinitialvirologicsuppressioninroutinehivprograminkenya AT odhiambojacobo uptakeandeffectofuniversaltestandtreatontwelvemonthsretentionandinitialvirologicsuppressioninroutinehivprograminkenya AT yegonpeterk uptakeandeffectofuniversaltestandtreatontwelvemonthsretentionandinitialvirologicsuppressioninroutinehivprograminkenya AT omorogonzao uptakeandeffectofuniversaltestandtreatontwelvemonthsretentionandinitialvirologicsuppressioninroutinehivprograminkenya AT mbairecatherine uptakeandeffectofuniversaltestandtreatontwelvemonthsretentionandinitialvirologicsuppressioninroutinehivprograminkenya AT masamarokennethm uptakeandeffectofuniversaltestandtreatontwelvemonthsretentionandinitialvirologicsuppressioninroutinehivprograminkenya AT njogosusanm uptakeandeffectofuniversaltestandtreatontwelvemonthsretentionandinitialvirologicsuppressioninroutinehivprograminkenya AT barkerjosephl uptakeandeffectofuniversaltestandtreatontwelvemonthsretentionandinitialvirologicsuppressioninroutinehivprograminkenya AT ngugicatherinen uptakeandeffectofuniversaltestandtreatontwelvemonthsretentionandinitialvirologicsuppressioninroutinehivprograminkenya |